BioSpace News Archive

Bio NC

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023

ProKidney Corp. announced that the Company will present four posters discussing investigations into the mechanism of action and clinical outcomes observed with REACT® at the upcoming American Society of Nephrology’s Kidney Week being held on November 2-5, 2023, in Philadelphia, PA.

October 30, 2023
·
6 min read
BioCapital

Immunocore to present at upcoming November 2023 investor conferences

Immunocore Holdings Plc announced that management will present at the following investor conferences in November:

October 30, 2023
·
1 min read
Drug Development

Annovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)

Annovis Bio, Inc. (NYSE: ANVS), announces the positive safety review by the Data and Safety Monitoring Board (DSMB) for its phase 2/3 trial of buntanetap, a drug candidate for moderate to mild Alzheimer’s Disease (AD) patients.

October 30, 2023
·
3 min read
Business

Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will release third quarter 2023 financial results on Thursday, November 2, 2023.

October 30, 2023
·
1 min read
Business

Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today announced preliminary unaudited financial results for the fiscal third quarter ended September 30, 2023.

October 30, 2023
·
8 min read
Job Trends

Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes

Bristol Myers Squibb (NYSE: BMY) today announced that it has priced a public offering (the “Offering”) of senior unsecured notes in a combined aggregate principal amount of $4.5 billion (collectively, the “Notes”).

October 30, 2023
·
4 min read
Business

Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer

Dren Bio, Inc. , today announced the expansion of its leadership team with the appointment of Amit Mehta, Ph.D., as the Company’s Chief Operating Officer and Chief Business Officer.

October 30, 2023
·
3 min read
Deals

Alzamend Neuro Announces Reverse Stock Split

Alzamend Neuro, Inc. today announced that Alzamend’s board of directors approved a one-for-fifteen reverse stock split of Alzamend’s common stock.

October 30, 2023
·
3 min read
Drug Development

Allyx Therapeutics Lead Compound ALX-001 is Safe and Tolerable at Doses, Achieving Full Brain Target Engagement in Healthy Older Adults

Allyx Therapeutics presented Phase 1a single ascending dose study results at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) meeting in Boston on October 27, 2023.

October 30, 2023
·
3 min read
Salignostics’ Salistick, the World’s First Saliva-Based Pregnancy Test, Recognized by TIME as One of the Best Inventions of 2023

Salignostics, an Israeli saliva research and product development start-up, is proud to announce its groundbreaking pregnancy test, Salistick, has been selected as one of TIME magazine’s Best Inventions of 2023.

October 30, 2023
·
3 min read